Smith & Nephew SNATS Inc - Asset Resilience Ratio
Smith & Nephew SNATS Inc (SNN) has an Asset Resilience Ratio of -0.69% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Smith & Nephew SNATS Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1985–2021)
This chart shows how Smith & Nephew SNATS Inc's Asset Resilience Ratio has changed over time. See Smith & Nephew SNATS Inc (SNN) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Smith & Nephew SNATS Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Smith & Nephew SNATS Inc stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-69.00 Million | -0.69% |
| Total Liquid Assets | $-69.00 Million | -0.69% |
Asset Resilience Insights
- Limited Liquidity: Smith & Nephew SNATS Inc maintains only -0.69% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Smith & Nephew SNATS Inc Industry Peers by Asset Resilience Ratio
Compare Smith & Nephew SNATS Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.47% |
|
Implanet SA
PA:ALIMP |
Medical Devices | 0.55% |
|
BBS-Bioactive Bone Substitutes Oyj
HE:BONEH |
Medical Devices | 15.58% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
Annual Asset Resilience Ratio for Smith & Nephew SNATS Inc (1985–2021)
The table below shows the annual Asset Resilience Ratio data for Smith & Nephew SNATS Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | -1.67% | $-182.00 Million | $10.92 Billion | -0.46pp |
| 2020-12-31 | -1.21% | $-133.00 Million | $11.01 Billion | -0.07pp |
| 2019-12-31 | -1.14% | $-106.00 Million | $9.30 Billion | +0.00pp |
| 2018-12-31 | -1.14% | $-92.00 Million | $8.06 Billion | -0.35pp |
| 2017-12-31 | -0.79% | $-62.00 Million | $7.87 Billion | -0.80pp |
| 2015-12-31 | 0.01% | $1.00 Million | $7.17 Billion | -2.95pp |
| 2012-12-31 | 2.96% | $167.00 Million | $5.64 Billion | -0.03pp |
| 2011-12-31 | 2.99% | $142.00 Million | $4.75 Billion | +2.68pp |
| 2009-12-31 | 0.31% | $14.00 Million | $4.57 Billion | -4.16pp |
| 2005-12-31 | 4.47% | $133.00 Million | $2.98 Billion | -2.12pp |
| 2004-12-31 | 6.59% | $192.27 Million | $2.92 Billion | -8.84pp |
| 2003-12-31 | 15.43% | $342.86 Million | $2.22 Billion | -- |
| 2000-12-31 | 0.00% | $0.00 | $1.44 Billion | -- |
| 1999-12-31 | 0.00% | $0.00 | $1.59 Billion | -- |
| 1998-12-31 | 0.00% | $0.00 | $1.50 Billion | -- |
| 1997-12-31 | 0.00% | $0.00 | $1.43 Billion | -- |
| 1996-12-31 | 0.00% | $0.00 | $1.44 Billion | -- |
| 1995-12-31 | 0.10% | $1.24 Million | $1.27 Billion | -0.13pp |
| 1994-12-31 | 0.22% | $2.97 Million | $1.32 Billion | 0.00pp |
| 1993-12-31 | 0.23% | $2.96 Million | $1.31 Billion | -0.77pp |
| 1991-12-31 | 0.99% | $15.72 Million | $1.58 Billion | -6.44pp |
| 1990-12-31 | 7.43% | $114.00 Million | $1.53 Billion | -1.81pp |
| 1989-12-31 | 9.24% | $125.00 Million | $1.35 Billion | +3.48pp |
| 1988-12-31 | 5.76% | $73.34 Million | $1.27 Billion | -2.86pp |
| 1987-12-31 | 8.62% | $105.86 Million | $1.23 Billion | +2.47pp |
| 1986-12-31 | 6.16% | $54.70 Million | $888.50 Million | -2.22pp |
| 1985-12-31 | 8.37% | $53.88 Million | $643.40 Million | -- |
About Smith & Nephew SNATS Inc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more